In China, 5-year survival rates of HCC have been reported to be as low as 12% (9), mainly ascribed to its insidious onset, lack of obvious symptoms in the early stage, rapid progression and difficulty of early effective diagnosis through current non-invasive clinical screening technology like serum alpha-fetoprotein (AFP) and imaging examination (10). This evidence concerns the gene AFP and hepatocellular carcinoma.